HME Square

is a Korean digital healthcare company founded in 2020 with the slogan "We listen to your glucose." The company specializes in developing non-invasive health data measurement technology and medical devices. Its core technologies include photoacoustics, MEMS device technology, and deep learning, all of which are integrated into a digital data platform aimed at promoting healthy living. HME Square's flagship product, GlucoSOUND, is designed to enable accurate and continuous blood glucose measurement without the need for blood sampling or needles. Currently in the final stage of preclinical evaluation, it is set to commence clinical trials soon. The company's vision is to facilitate a digital healthcare revolution by offering products and services for real-time health monitoring, with the ultimate goal of preventing chronic diseases and enhancing people's quality of life. In December 12, 2023, HME Square secured a KRW4.00B investment in a Seed Round from LB Investment and KB Investments. With its innovative approach to healthcare technology, HME Square is poised to make a significant impact in the Health Care industry from its headquarters in South Korea.